Validation of a DNA Methylation Signature of Favorable Prognosis in Newly Diagnosed Acute Myeloid Leukemia.

被引：0

作者：

Taby, Rodolphe F. ^{[1
]}

Yellapragada, Sarvari Venkata ^{[2
,3
]}

Kroeger, Heike ^{[1
]}

He, Rong ^{[1
]}

Kornblau, Steven M. ^{[4
]}

Kantarjian, Hagop ^{[1
]}

Ravandi, Farhad ^{[1
]}

Jelinek, Jaroslav ^{[1
]}

Issa, Jean-Pierre J. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Michael E DeBakey VA Med Ctr, Dept Hematol Oncol, Houston, TX USA

[3] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：645 / 645

页数：1

共 50 条

[31] Dysregulation of ultra long-range DNA methylation canyon interactions in human acute myeloid leukemia.
Wang, Xue Qing D.
Feng, Fan
Dou, Yali
Liu, Jie
Zhang, Xiaotian
CANCER RESEARCH, 2022, 82 (23)
[32] Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Roellig, Christoph
Kramer, Michael
Schliemann, Christoph
Mikesch, Jan-Henrik
Steffen, Bjoern
Kramer, Alwin
Noppeney, Richard
Schaefer-Eckart, Kerstin
Krause, Stefan W.
Haenel, Mathias
Herbst, Regina
Kunzmann, Volker
Einsele, Hermann
Jost, Edgar
Bruemmendorf, Tim H.
Scholl, Sebastian
Hochhaus, Andreas
Neubauer, Andreas
Sohlbach, Kristina
Fransecky, Lars
Kaufmann, Martin
Niemann, Dirk
Schaich, Markus
Frickhofen, Norbert
Kiani, Alexander
Heits, Frank
Kruempelmann, Ulrich
Kaiser, Ulrich
Kullmer, Johannes
Wass, Maxi
Stoelzel, Friedrich
von Bonin, Malte
Middeke, Jan Moritz
Thiede, Christian
Schetelig, Johannes
Berdel, Wolfgang E.
Ehninger, Gerhard
Baldus, Claudia D.
Muller-Tidow, Carsten
Platzbecker, Uwe
Serve, Hubert
Bornhaeuser, Martin
BLOOD, 2020, 136 (07) : 823 - 830
[33] Modified Conut Score Can Predict Prognosis in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
Senjo, Hajime
Onozawa, Masahiro
Hidaka, Daisuke
Yokoyama, Shota
Yamamoto, Satoshi
Tsutsumi, Yutaka
Haseyama, Yoshihito
Nagashima, Takahiro
Mori, Akio
Ota, Shuichi
Sakai, Hajime
Ishihara, Toshimichi
Miyagishima, Takuto
Kakinoki, Yasutaka
Kurosawa, Mitsutoshi
Kobayashi, Hajime
Iwasaki, Hiroshi
Kondo, Takeshi
Teshima, Takanori
BLOOD, 2019, 134
[34] Acute myeloid leukemia.: Reply
Löwenberg, B
Burnett, AK
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (05): : 358 - 359
[35] Cytogenetics in acute myeloid leukemia.
Schoch C.
Haferlach T.
Current Oncology Reports, 2002, 4 (5) : 390 - 397
[36] Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
Wang, Jinghan
Ye, Wenle
Yan, Xiao
Guo, Qi
Ma, Qiuling
Lin, Fang
Huang, Jiansong
Jin, Jie
JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
[37] Hypoplastic acute myeloid leukemia.
Park, Hye-Won
Lee, Je-Hwan
Choi, Seong-Jun
Lee, Jung-Hee
Seol, Miee
Lee, Young-Shin
Ryu, Seong-Gil
Kim, Keum Hee
Jang, Seongsoo
Seo, Eul-Joo
Park, Chan-Jeoung
BLOOD, 2006, 108 (11) : 202B - 202B
[38] NOVEL IMMUNOPHENOTYPING MARKER IN ACUTE MYELOID LEUKEMIA. DOES IT IMPLICATE PROGNOSIS?
El-Naby, Amira Y. Abd
Gawaly, Amr
Amer, Eman A.
LEUKEMIA RESEARCH, 2015, 39 : SS19 - SS19
[39] Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
Jinghan Wang
Wenle Ye
Xiao Yan
Qi Guo
Qiuling Ma
Fang Lin
Jiansong Huang
Jie Jin
Journal of Translational Medicine, 17
[40] Updates on DNA methylation modifiers in acute myeloid leukemia
Bruna Contieri
Bruno Kosa Lino Duarte
Mariana Lazarini
Annals of Hematology, 2020, 99 : 693 - 701

← 1 2 3 4 5 →